Michael Bigham, Director at SUPERNUS PHARMACEUTICALS INC (SUPN), bought 35,000 shares at $5.65 ($189K) on 2013-03-22, disclosed to the SEC on 2013-03-26.
Open-market purchase of $189k SUPN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.17 | 5,000 | $26K | 13.7% |
| 2 | $5.20 | 5,000 | $26K | 13.7% |
| 3 | $5.26 | 10,000 | $53K | 27.8% |
| 4 | $5.65 | 15,000 | $85K | 44.8% |
| Total | $5.41 avg | 35,000 | $189K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |